Network origin in Jacob Sage first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Eboo Pharmaceuticals, Inc.
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jacob Sage via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ONCOLOGY PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
| ATHENEXPAR | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Biotechnology | Founder | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Concordia University | College/University | Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Saskatchewan College of Medicine | College/University | Doctorate Degree | |
Ballantyne Therapeutics, Inc.
 Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Pharmaceuticals: Major | Director/Board Member | |
Atlantic Research Group, Inc.
 Atlantic Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Atlantic Research Group, Inc. operates as a rare disease-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. It offers strategic consulting, clinical trial management services, clinic data and analytics solutions, pharmacovigilance and medical monitoring. The company was founded by Paul Bishop and Lyle Camblos in 2004 and is headquartered in Charlottesville, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer |
Statistics
International
| United States | 16 |
| Canada | 4 |
Sectoral
| Health Technology | 14 |
| Consumer Services | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 9 |
| Corporate Officer/Principal | 6 |
| President | 5 |
| Chief Executive Officer | 5 |
| Independent Dir/Board Member | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Simon Pedder | 19 |
| Jonathon Brotchie | 1 |
- Stock Market
- Insiders
- Jacob Sage
- Company connections
